Details for 2012820058

Up to date per 03.04.2026

Actions

Title / Product Name

VERWENDUNG VON (1R,5S)-(+)-1-(NAPHTALEN-2-YL)-3-AZABICYCLO-{3.1.0-}HEXAN BEI DER BEHANDLUNG VON DURCH MONOAMIN-NEUROTRANSMITTER VERMITTELTEN LEIDEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2012820058

EP Publication Number

2819516

E-Number

1216367

Language

PCT Number

US12000335

Publication Date

07.01.2015 A

25.12.2019 B1

Registration Date

25.12.2019

AT Publication Date

15.01.2020

Application Date

27.07.2012

Registration Number

Priorities

30.07.2011

201161574231 P

22.12.2011

201113334066

21.06.2012

201213528940

IPC

A61K 9/00 20060101AFI20190619BHEP

Maximum Duration of Protection

27.07.2032

Owner

Otsuka America Pharmaceutical, Inc.2440 Research Boulevard Rockville, MD 20850US

Representative

Barger W. Dipl.Ing., Israiloff P. Dipl.Ing. Dr. techn.Operngasse 41010 WienAT

Inventor

MCKINNEY, Anthony Alexander38 Braeland Avenue Suite 2 Newton Center, MA 02459US

BYMASTER, Frank8545 North County Road 650 East Brownsburg, IN 46112US

Information about Fees